Checkpoint inhibitor‐induced bullous pemphigoid differs from spontaneous bullous pemphigoid-Reference-Cited by-同舟云学术

Checkpoint inhibitor‐induced bullous pemphigoid differs from spontaneous bullous pemphigoid

Published:2024-02-24 Issue:8 Volume:38 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Kramer N.¹^ORCID,Müller G.¹,Zierold S.¹,Röckel M.²,Fröhlich W.²,Schefzyk M.³,Kumbrink J.⁴,Hassel J. C.⁵,Berking C.²,Ziemer M.⁶^ORCID,Nashan D.⁷,French L. E.¹⁸^ORCID,Vera J.²,Kerl‐French K. E.¹,Gutzmer R.⁹,Heinzerling L.¹²

Affiliation:

1. Department of Dermatology and Allergology, University Hospital LMU Munich Munich Germany

2. Department of Dermatology, Uniklinikum Erlangen, Comprehensive Cancer Center Erlangen – EMN Friedrich‐Alexander University Erlangen‐Nürnberg Erlangen Germany

3. Department of Dermatology and Allergy Hannover Medical School Hannover Germany

4. Institute of Pathology, Faculty of Medicine LMU Munich Munich Germany

5. Department of Dermatology, National Center for Tumor Diseases (NCT) Heidelberg University Hospital Heidelberg Germany

6. Department of Dermatology, Allergology and Venerology University Medical Center Leipzig Germany

7. Department of Dermatology Hospital Dortmund Dortmund Germany

8. Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery University of Miami, Miller School of Medicine Miami Florida USA

9. Department of Dermatology, Johannes Wesling Medical Center Ruhr University Bochum Campus Minden Minden Germany

Funder

Bundesministerium für Bildung und Forschung

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.19860

Reference10 articles.

1. Checkpoint inhibitors;Heinzerling L;Dtsch Arztebl Int,2019

2. Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational study

3. Retrospective Analysis of Checkpoint Inhibitor Therapy-Associated Cases of Bullous Pemphigoid From Six German Dermatology Centers

4. Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer

5. Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-programmed Cell Death Ligand 1 Therapy: A Review of the Literature

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The possible and intriguing relationship between bullous pemphigoid and melanoma: speculations on significance and clinical relevance;Frontiers in Immunology;2024-08-29

2. Arzneimittelexantheme unter Immun- und zielgerichteter onkologischer Therapie;Die Dermatologie;2024-05-21

3. Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors;European Journal of Cancer;2024-05